Thomas Hehr

Imaging-based target volume reduction in chemoradiotherapy for locally advanced non-small-cell lung cancer (PET-Plan): a multicentre, open-label, randomised, controlled trial

Ursula Nestle, Tanja Schimek‐Jasch, Stephanie Kremp et al. · The Lancet Oncology · 2020 · 169 citations

Engineering, Oncologic Imaging, Medical Imaging +9

Oral Diadochokinesis in Neurological Dysarthrias

Hermann Ackermann, Ingo Hertrich, Thomas Hehr · Folia Phoniatrica et Logopaedica · 1995 · 156 citations

Speech Kinematics, Neurological Disorder, Pathological Speech +17

18F-FDG PET for assessment of therapy response and preoperative re-evaluation after neoadjuvant radio-chemotherapy in stage III non-small cell lung cancer

S. Eschmann, Godehard Friedel, Frank Paulsen et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2006 · 128 citations

Positron Emission Tomography, Oncologic Imaging, Radiation Therapy +10

Hypoxia-imaging with 18F-Misonidazole and PET: Changes of kinetics during radiotherapy of head-and-neck cancer

S. Eschmann, Frank Paulsen, Claudia Bedeshem et al. · Radiotherapy and Oncology · 2007 · 119 citations

Positron Emission Tomography, Oncologic Imaging, Radiation Therapy +11

Is standardised 18F-FDG uptake value an outcome predictor in patients with stage III non-small cell lung cancer?

S. M. Eschmann, Godehard Friedel, Frank Paulsen et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2005 · 92 citations

Advanced Lung Disease, Medicine, Bronchial Neoplasm +8